Lee Sang Pyo, Sung In-Kyung, Kim Jeong Hwan, Lee Sun-Young, Park Hyung Seok, Shim Chan Sup
Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
Korean J Fam Med. 2019 Sep;40(5):314-322. doi: 10.4082/kjfm.18.0057. Epub 2019 Apr 8.
Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker whose level is elevated in many types of cancers and other benign conditions. CA 19-9 levels are frequently found to be elevated in individuals during general health examinations. This study aimed to investigate the clinical characteristics of such individuals and to determine the need for medical follow-up.
We investigated individuals who underwent a health inspection, including a serum CA 19-9 test, at our center. Their CA 19-9 levels, age, sex, body mass index (BMI), and personal and past histories were investigated. Additionally, subgroup analyses were performed for those who underwent follow-up study for the elevated CA 19-9 levels.
Of 58,498 subjects, 581 (1.0%) had elevated CA 19-9 levels. Multivariate analyses revealed that older age, female sex, lower BMI, and diabetes were independent predisposing factors for elevated CA 19-9 level. A subgroup analysis revealed that the causative conditions were identified in 129 of 351 subjects (36.8%). Among them, the causative conditions in 31 subjects (8.8%, including four cases of cancer and 15 of benign tumors) were not detected at the initial check-up and were found during the follow-up period.
The use of CA 19-9 as a marker for cancer in healthy individuals is inappropriate. However, medical follow-up in individuals with elevated CA 19-9 levels may be useful because some causative diseases may be detected during follow-up.
糖类抗原19-9(CA 19-9)是一种肿瘤标志物,其水平在多种癌症及其他良性疾病中会升高。在一般健康检查中,经常发现个体的CA 19-9水平升高。本研究旨在调查此类个体的临床特征,并确定是否需要医学随访。
我们调查了在本中心接受包括血清CA 19-9检测在内的健康检查的个体。调查了他们的CA 19-9水平、年龄、性别、体重指数(BMI)以及个人史和既往史。此外,对CA 19-9水平升高并接受随访研究的个体进行了亚组分析。
在58498名受试者中,581名(1.0%)的CA 19-9水平升高。多因素分析显示,年龄较大、女性、BMI较低和糖尿病是CA 19-9水平升高的独立易感因素。亚组分析显示,351名受试者中有129名(36.8%)的致病原因得以明确。其中,31名受试者(8.8%,包括4例癌症和15例良性肿瘤)的致病原因在初次检查时未被发现,而是在随访期间发现的。
将CA 19-9用作健康个体癌症标志物是不合适的。然而,对CA 19-9水平升高的个体进行医学随访可能是有用的,因为在随访期间可能会发现一些致病疾病。